# Teucrium Commodity Trust: financial statements, quarterly

BTCK · NYSE · CIK 1471824 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/btck.md) · [Financials](/companies/btck/financials.md) · [Filings](/companies/btck/filings.md) · [Insiders](/companies/btck/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/btck/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [12.4](/filings/0001437749-23-030851.md) | [(41.6) d](/filings/0001437749-25-006324.md) | [(28.1)](/filings/0001437749-24-015957.md) | [(20.4)](/filings/0001437749-24-025754.md) | [(26.5)](/filings/0001437749-24-034484.md) | [11.1 d](/filings/0001437749-25-006324.md) | [(21.5)](/filings/0001437749-24-015957.md) | [(8.8)](/filings/0001437749-24-025754.md) | [2.0](/filings/0001437749-24-034484.md) | [(11.1) d](/filings/0001437749-25-006324.md) | not reported | not reported |
| Net income | $m | [9.2](/filings/0001437749-23-030851.md) | [(44.6) d](/filings/0001437749-25-006324.md) | [(30.5)](/filings/0001437749-24-015957.md) | [(22.8)](/filings/0001437749-24-025754.md) | [(29.0)](/filings/0001437749-24-034484.md) | [8.8 d](/filings/0001437749-26-006385.md) | [(23.5)](/filings/0001437749-24-015957.md) | [(10.9)](/filings/0001437749-24-025754.md) | [(0.1)](/filings/0001437749-24-034484.md) | [(13.4) d](/filings/0001437749-26-006385.md) | [(3.1)](/filings/0001437749-26-016164.md) | [30.4](/filings/0001437749-26-016164.md) |
| Basic EPS | $ per share | not reported | not reported | [1.93](/filings/0001437749-24-015957.md) | not reported | not reported | not reported | [1.05](/filings/0001437749-24-015957.md) | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [323](/filings/0001437749-23-030851.md) | [292](/filings/0001437749-25-006324.md) | [254](/filings/0001437749-24-015957.md) | [228](/filings/0001437749-24-025754.md) | [233](/filings/0001437749-24-034484.md) | [211](/filings/0001437749-26-006385.md) | [191](/filings/0001437749-25-016101.md) | [190](/filings/0001437749-25-025918.md) | [204](/filings/0001437749-25-034040.md) | [205](/filings/0001437749-26-027963.md) | [641](/filings/0001437749-26-016164.md) | [533](/filings/0001437749-26-027963.md) |
| Total assets | $m | [369](/filings/0001437749-23-030851.md) | [326](/filings/0001437749-25-006324.md) | [297](/filings/0001437749-24-015957.md) | [268](/filings/0001437749-24-025754.md) | [257](/filings/0001437749-24-034484.md) | [242](/filings/0001437749-25-006324.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [27.4](/filings/0001437749-23-030851.md) | [11.4](/filings/0001437749-25-006324.md) | [18.9](/filings/0001437749-24-015957.md) | [27.0](/filings/0001437749-24-025754.md) | [10.2](/filings/0001437749-24-034484.md) | [17.0](/filings/0001437749-25-006324.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported

## Cash flow

| Line item | Unit | period not labelled (2022-03-31) | period not labelled (2022-06-30) | period not labelled (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.2](/filings/0001437749-23-013498.md) | [(56.4) d](/filings/0001437749-23-022779.md) | [(22.8) d](/filings/0001437749-23-030851.md) | [(27.3) d](/filings/0001437749-25-006324.md) | [(17.0)](/filings/0001437749-24-015957.md) | [(6.0) d](/filings/0001437749-24-025754.md) | [(38.3) d](/filings/0001437749-24-034484.md) | [5.6 d](/filings/0001437749-25-006324.md) | [(25.5)](/filings/0001437749-24-015957.md) | [0.2 d](/filings/0001437749-24-025754.md) | [(1.6) d](/filings/0001437749-24-034484.md) | [(12.6) d](/filings/0001437749-25-006324.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 7,800,004 at 2022-11-08, from the cover of the [10-Q filed 2022-11-09](/filings/0001654954-22-014879.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.